| PERIOD ENDING | 3-Jan-09 | 29-Dec-07 | 30-Dec-06 | | Total Revenue | 48,528 | 55,532 | 35,904 | | Cost of Revenue | 28,849 | 31,248 | 17,099 | | | Gross Profit | 19,679 | 24,284 | 18,805 | | | Operating Expenses | | Research Development | 4,009 | 5,779 | 5,511 | | Selling General and Administrative | 17,842 | 27,930 | 18,059 | | Non Recurring | 5,364 | 14,690 |
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (7,536) | (24,115) | (4,765) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 800 | 2,500 | 733 | | Earnings Before Interest And Taxes | (6,736) | (21,615) | (4,032) | | Interest Expense | 507 | 644 |
-
| | Income Before Tax | (7,243) | (22,259) | (4,032) | | Income Tax Expense | 127 | 13 | 1,721 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (7,370) | (22,272) | (5,753) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (7,370) | (22,272) | (5,753) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($7,370) | ($22,272) | ($5,753) |
|
1.43% Nasdaq 
0.02 (0.63%) 
Income Statement
